Analysts Reports


-
Immuron Equity Report (Oct 2019)
-
Immuron takes aim at the rapid growth of autoimmune diseases
-
Immuron surges 28pc after study shows tablets fight Bali Belly in US soldiers (Jan 2018)
-
Van Leeuwenhoeck Institute Updated Report (Nov 2017)
-
Emerging Biologics in Fatty-Liver and Infectious Disease Management (Sep 2017)
-
BioShares Report - Edition 687 (Mar 2017)
-
Van Leeuwenhoeck Institute Report - Substantial Re-rating in NASH (Feb 2017)
-
Van Leeuwenhoeck Institute Independent Research Note (Jan 2017)
-
SeeThru Equity Analyst Report (Feb 2016)
-
Red Chip C-Difficile Analyst Report (Jan 2016)
-
Red Chip Analyst Report (Aug 2015)